Skip to content
Hi-Doctor

How to Get Suvorexant (Belsomra) Online in Sweden

Struggling with insomnia in Sweden? Learn how to get a Suvorexant (Belsomra) prescription online from an EU-licensed doctor for just €25. Receive your valid REMPE prescription in under 24 hours, valid at any EU pharmacy.

11 April 2026
How to Get Suvorexant (Belsomra) Online in Sweden —

DIRECT ANSWER

An online consultation lets an EU-licensed doctor review your case and, if appropriate, issue a prescription that is valid across the EU.

Less than 4 hours on average

Prescription issued in less than 4 hours on average if approved.

EU-licensed doctors

Every case is reviewed by a licensed clinician.

Valid across the EU

Approved prescriptions can be used at any EU pharmacy.

In this article

Yes, you can get a Suvorexant (Belsomra) prescription online in Sweden through a licensed EU doctor, without an in-person clinic visit. If you're struggling with insomnia, Hi-Doctor.ai connects you with EU-licensed medical professionals who can assess your case quickly and confidentially. The process is straightforward: a €25 online consultation, a prescription within 24 hours if appropriate, and the ability to collect your medication at any pharmacy across the EU.

How it works — get your Suvorexant prescription in 4 steps

  1. Fill out a brief online medical questionnaire (takes 2–3 minutes) and pay the flat €25 consultation fee.
  2. An EU-licensed doctor privately reviews your medical information. If the doctor determines Suvorexant is not appropriate for you, your €25 fee is refunded automatically — no risk, you pay nothing.
  3. If approved, you receive a REMPE electronic prescription (a secure, downloadable PDF file) directly in your Hi-Doctor account and by email within 24 hours.
  4. Print the PDF or show it on your phone — present it at any pharmacy in the EU to collect your Suvorexant.

Who qualifies for Suvorexant (Belsomra)

When you consult with an EU-licensed doctor via Hi-Doctor.ai, they will evaluate your case to determine if Suvorexant (Belsomra) is a suitable treatment for your insomnia. Doctors look for specific criteria, including:

  • A diagnosis of insomnia, characterized by difficulty falling asleep or staying asleep.
  • No history of severe liver impairment.
  • Absence of narcolepsy or other severe sleep disorders.
  • No known allergies to suvorexant or any of its components.
  • Not currently taking other medications that interact negatively with suvorexant.
  • No history of severe respiratory depression.

Your doctor will consider your full medical history to ensure Suvorexant is safe and effective for your individual needs.

What Suvorexant (Belsomra) actually does (and doesn't do)

Suvorexant, marketed as Belsomra, is a prescription medication designed to treat insomnia. It works differently from older sleep aids. Instead of broadly sedating the brain, Suvorexant targets specific brain chemicals called orexins. Orexins are neurotransmitters that promote wakefulness.

Suvorexant acts as an orexin receptor antagonist, meaning it blocks the action of orexins. By doing so, it helps to reduce the signals that keep you awake, making it easier to fall asleep and stay asleep. Clinical studies show it can improve both sleep onset and sleep maintenance. It aims to restore a more natural sleep-wake cycle without the higher risk of dependence associated with some other sleep medications. Suvorexant does not guarantee immediate sleep for everyone, but it helps promote the conditions for sleep, and its effects become more consistent with continued use as prescribed.

Side effects and when to stop

Like all medications, Suvorexant (Belsomra) can cause side effects. It's important to be aware of these and discuss them with your doctor.

Common side effects include:

  • Drowsiness or feeling sleepy the next day
  • Headache
  • Dizziness
  • Abnormal dreams or nightmares
  • Dry mouth

More serious, though rare, side effects can occur. These include temporary inability to move or speak upon waking (sleep paralysis), hallucinations, or complex sleep-related behaviors such as sleepwalking, sleep-driving, or preparing and eating food while not fully awake. If you experience any of these serious side effects, or a severe allergic reaction (rash, itching, swelling, severe dizziness, trouble breathing), stop taking Suvorexant immediately and seek urgent medical attention.

Always tell your doctor about any new or worsening symptoms. They will advise if Suvorexant is still appropriate or if you should discontinue use.

Why Hi-Doctor vs. walking into a clinic

Getting a Suvorexant prescription for insomnia in Sweden traditionally means navigating appointments and waiting times. Hi-Doctor offers a modern, patient-focused alternative:

  • Speed: Receive your prescription in under 24 hours with Hi-Doctor, compared to weeks for an in-person appointment.
  • Price: A flat €25 consultation fee with Hi-Doctor. If the doctor determines treatment is not appropriate, you get your money back. Traditional private clinic fees can vary significantly.
  • Privacy: Everything happens within your secure Hi-Doctor account, ensuring your medical information and consultations remain private, unlike a public reception desk.
  • Convenience: Consult with an EU-licensed doctor from your phone or computer, anywhere, anytime. No travel, no waiting room.
  • Trust: Join over 50,000 satisfied patients. We hold a 4.8 Trustpilot rating, reflecting our commitment to quality and patient care.

Hi-Doctor provides a private, efficient, and cost-effective way to access necessary medication from EU-licensed doctors, all while complying with RGPD privacy standards.

COMMON QUESTIONS

Frequently asked questions

If the EU-licensed doctor determines that Suvorexant is not the appropriate treatment for you, your €25 consultation fee is automatically refunded. You pay nothing if the treatment isn't approved.

Licensed EU doctors
Doctor review in less than 2 hours on average
50,000+ patients served
Secure patient account
Online Doctor Legitimacy and EU Regulations Explained — article cover image

Online Doctor Legitimacy and EU Regulations Explained

This article clarifies the legitimacy of online doctor services within the European Union, detailing the regulations that ensure patient safety and the validity of cross-border prescriptions.

14 August 2026
Understanding REMPE Electronic Prescriptions: A Guide for EU Patients — article cover image

Understanding REMPE Electronic Prescriptions: A Guide for EU Patients

This guide explains the Spanish REMPE electronic prescription system, its function within Spain, and its recognition across the EU. It clarifies how these prescriptions are reviewed and processed by pharmacists, both.

13 August 2026
Zavamed Alternatives: 8 Options Compared (2026) — article cover image

Zavamed Alternatives: 8 Options Compared (2026)

Looking for Zavamed alternatives in 2026? We compare 8 online health services by market, treatment coverage and supported consultation or fulfilment model.

6 August 2026
Dokteronline Alternatives: 8 Options Compared (2026) — article cover image

Dokteronline Alternatives: 8 Options Compared (2026)

Looking for Dokteronline alternatives? We compare 8 online healthcare services across the EU, UK and US, with clear market labels and service-model differences.

6 August 2026
Best Telehealth Men's Health Services in Spain (2026) — article cover image

Best Telehealth Men's Health Services in Spain (2026)

We compare seven telehealth men's health services available in Spain in 2026, from EU e-prescription platforms to doctor-directory and generalist services covering sexual health, hair growth and weight management.

6 August 2026
Best Online ED Treatment Providers in Europe (2026) — article cover image

Best Online ED Treatment Providers in Europe (2026)

Compare the top online ED treatment providers in Europe for 2026. We evaluate services by their consultation model, market availability, and approach to sexual healthcare.

6 August 2026

HI-DOCTOR NEWSLETTER

We'll tell you when we add new treatments.

At most 2 emails a month. No spam. Updates on online health, EU telemedicine, and clinical guides signed by licensed doctors.